Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neurocrine Biosciences (NBIX) Times Interest Earned (2017 - 2024)

Neurocrine Biosciences filings provide 8 years of Times Interest Earned readings, the most recent being $90.27 for Q1 2024.

  • On a quarterly basis, Times Interest Earned rose 186.95% to $90.27 in Q1 2024 year-over-year; TTM through Dec 2024 was $518.64, a 850.87% increase, with the full-year FY2023 number at $54.54, up 55.53% from a year prior.
  • Times Interest Earned hit $90.27 in Q1 2024 for Neurocrine Biosciences, down from $136.64 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of $136.64 in Q4 2023 to a low of -$103.82 in Q1 2023.
  • Median Times Interest Earned over the past 5 years was $9.23 (2020), compared with a mean of $31.65.
  • Biggest five-year swings in Times Interest Earned: soared 1809.09% in 2022 and later crashed 8807.33% in 2023.
  • Neurocrine Biosciences' Times Interest Earned stood at $9.21 in 2020, then tumbled by 159.75% to -$5.5 in 2021, then soared by 1809.09% to $94.0 in 2022, then surged by 45.36% to $136.64 in 2023, then plummeted by 33.93% to $90.27 in 2024.
  • The last three reported values for Times Interest Earned were $90.27 (Q1 2024), $136.64 (Q4 2023), and $128.36 (Q3 2023) per Business Quant data.